This page may have documents that can’t be read by screen reader software. For help with these documents, please call 1-800-975-6314.
On Jan. 10, the federal government released guidance about coverage of over-the-counter COVID-19 diagnostic tests.
What this means: We are evaluating the guidance to determine how it affects our current COVID-19 testing coverage. However, our early understanding is that the guidance:
Note: We'll publish an update in our BlueVISION newsletter with details about how members can submit OTC testing claims.
We will be updating our COVID-19 member microsite with details about how members can submit claims.